tiprankstipranks
Shanghai Junshi’s JS212 Drug Application Accepted, Boosting Cancer Therapy Pipeline
PremiumCompany AnnouncementsShanghai Junshi’s JS212 Drug Application Accepted, Boosting Cancer Therapy Pipeline
2M ago
Junshi Biosciences’ Toripalimab Gains Regular Approval for Melanoma Treatment
Premium
Company Announcements
Junshi Biosciences’ Toripalimab Gains Regular Approval for Melanoma Treatment
2M ago
Shanghai Junshi Biosciences Announces Board Structure
Premium
Company Announcements
Shanghai Junshi Biosciences Announces Board Structure
2M ago
Shanghai Junshi Biosciences Closes H Shares Register
PremiumCompany AnnouncementsShanghai Junshi Biosciences Closes H Shares Register
3M ago
Shanghai Junshi Biosciences Relocates Key Offices
Premium
Company Announcements
Shanghai Junshi Biosciences Relocates Key Offices
3M ago
Shanghai Junshi Unveils Strategic Financial Decisions
Premium
Company Announcements
Shanghai Junshi Unveils Strategic Financial Decisions
3M ago
Shanghai Junshi Biosciences Announces Q3 Results Briefing
PremiumCompany AnnouncementsShanghai Junshi Biosciences Announces Q3 Results Briefing
4M ago
Shanghai Junshi Biosciences Sees Key Shareholder Equity Shift
Premium
Company Announcements
Shanghai Junshi Biosciences Sees Key Shareholder Equity Shift
4M ago
Shanghai Junshi Biosciences Optimizes Investment Strategy
Premium
Company Announcements
Shanghai Junshi Biosciences Optimizes Investment Strategy
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100